Statements (56)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:healthcare_organization
|
| gptkbp:bfsLayer |
5
|
| gptkbp:bfsParent |
gptkb:gestational_trophoblastic_neoplasia
|
| gptkbp:affects |
fertility
|
| gptkbp:associated_with |
gptkb:human_chorionic_gonadotropin
|
| gptkbp:can_create |
elevated h CG levels
|
| gptkbp:can_lead_to |
gestational trophoblastic disease
|
| gptkbp:can_metastasize_to |
gptkb:theorem
gptkb:skincare_product liver lungs |
| gptkbp:caused_by |
fatigue
nausea weight loss abdominal pain vomiting hyperglycemia |
| https://www.w3.org/2000/01/rdf-schema#label |
h CG secreting tumors
|
| gptkbp:is_associated_with |
gptkb:healthcare_organization
gptkb:gestational_trophoblastic_neoplasia gptkb:choriocarcinoma ovarian cancer environmental factors lifestyle factors metabolic disorders genetic mutations autoimmune disorders hormonal disorders placental site trophoblastic tumor |
| gptkbp:is_monitored_by |
h CG level testing
|
| gptkbp:is_recognized_by |
biopsy
|
| gptkbp:is_studied_in |
biomarkers
clinical trials patient demographics risk factors prognosis survival rates recurrence rates therapeutic targets treatment outcomes treatment responses molecular characteristics clinical features pathological features |
| gptkbp:occurs_in |
pregnant women
|
| gptkbp:participated_in |
hormonal changes
|
| gptkbp:recognizes |
blood test
|
| gptkbp:scientific_classification |
malignant tumors
benign tumors germ cell tumors non-germ cell tumors trophoblastic tumors |
| gptkbp:social_responsibility |
imaging studies
|
| gptkbp:treatment |
gptkb:hospital
radiation therapy chemotherapy |